Illume Fertility Appears in 5.8% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.

Mark HuntleyBy Mark HuntleyFounder and CEO
10 minutes read

Key Takeaways

  • Illume Fertility appears in 5.85% of benchmark answers, but recommendations are far lower at 0.63%.
  • Most mentions are neutral, which suggests visibility without strong endorsement.
  • The biggest opportunity is to improve affirmative recommendations, not just mention volume.
  • The plan focuses on verifying claims, reviewing cited pages, and creating content for insurance, affordability, and identity-specific care questions.

Answer Capsule

In November 2026, Illume Fertility appeared in 28 of 479 AI answers included in the Fertility Clinics benchmark (5.85%). It received 3 recommendations (0.63%), with 3 Top 3 placements and 1 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.

Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. This edition establishes a research baseline. It does not claim a change from earlier editions measured on a different basis. Conflicting AI claims require verification before corrections are proposed.

Current AI visibility

Questions This Section Answers

  • How do Illume Fertility mentions, recommendations and placements compare with its Fertility Clinics peers?

Illume Fertility recorded 28 mentions (5.85%) and 3 recommendations (0.63%) across 479 answers included in the benchmark. Top 3 placements numbered 3; first-place recommendations numbered 1. Framing among its mentions was 3 positive, 25 neutral and 0 negative.

Rank

Company

Mentions

Mention rate

Recommendations

Recommendation rate

Top 3

Top 3 rate

#1

#1 rate

1

CCRM Fertility

229

47.81%

135

28.18%

95

19.83%

45

9.39%

2

Shady Grove Fertility

190

39.67%

106

22.13%

83

17.33%

23

4.80%

3

RMA Network

154

32.15%

89

18.58%

56

11.69%

15

3.13%

4

NYU Langone Fertility

78

16.28%

63

13.15%

60

12.53%

18

3.76%

5

Spring Fertility

65

13.57%

40

8.35%

20

4.18%

3

0.63%

6

Pacific Fertility Center

62

12.94%

33

6.89%

23

4.80%

7

1.46%

7

Kindbody

69

14.41%

27

5.64%

5

1.04%

1

0.21%

8

Boston IVF

43

8.98%

22

4.59%

8

1.67%

6

1.25%

9

Illume Fertility

28

5.85%

3

0.63%

3

0.63%

1

0.21%

10

US Fertility

26

5.43%

0

0.00%

0

0.00%

0

0.00%

Illume Fertility appears in a modest share of benchmark answers, and its mentions are overwhelmingly neutral in tone. The gap that matters most is endorsement: appearances rarely carry a recommendation, and first-place placements are scarce. For a clinic competing against larger national networks, being named is a starting point, not a win.

The practical implication is that the client's near-term opportunity lies less in chasing raw mention volume than in earning affirmative, positively worded endorsements. The agency would build a scorecard that separates reach from endorsement so progress on each is tracked honestly, without treating appearances as if they were recommendations.

What changed since last month

Questions This Section Answers

  • How did Illume Fertility counts and coverage differ across the available monthly snapshots?

Metric

Nov 2026

Mentions

28 / 479 (5.85%)

Recommendations

3 / 479 (0.63%)

Top 3 recommendations

3 / 479 (0.63%)

#1 recommendations

1 / 479 (0.21%)

Only months with verified results are shown. Monthly sample coverage is listed in Methodology.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

This edition is the first broad baseline, so the monthly figures describe a single selected sample rather than a movement from earlier editions. Earlier editions used a narrower question set, which makes direct comparison misleading. The observed counts should be read as a starting reference point.

The useful takeaway is that future editions run on the same screening scope can be compared against this baseline. Until then, the agency would treat this month's record as the anchor for tracking, not as evidence of a trend in either direction.

AI recommendation trend

Observed recommendation rate (%), Nov 2026

  • Illume Fertilityno change
    Nov 20260.63%

Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.

/ Take the next step

Want to Understand Your AI Citation Footprint?

We start every engagement with a full audit of how AI systems reference your brand today.

Measurable, Repeatable Programme

Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge

Citation Architecture Review

Identify which high-authority community sources are and aren't working in your favour across AI platforms.

AI Visibility Audit

Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.

Step 1. Measure

Questions This Section Answers

  • What should the agency measure and verify first for Illume Fertility?

AI answers contained 0 conflicting claims about Illume Fertility: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No conflicting claims about Illume Fertility were recorded in the captured answers, so there is no immediate fact-check queue tied to the company. That is a clean starting position, but it does not confirm that every statement about the clinic is accurate; it means nothing disputed surfaced in this sample.

The agency would still build a visibility comparison against the named competitors and a short register of claims worth verifying from primary sources. Pairing the two lets the client see where it stands and which statements, if any, deserve confirmation before they are repeated in future content.

Step 2. Make the website consistent

Questions This Section Answers

  • Which recorded claim differences about Illume Fertility should be verified before proposed page edits?

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

No disputed-topic results were available for this part of the analysis, so there is nothing to correct or confirm yet. Any apparent conflict in AI answers would first need the entity, date and source resolved, since different dates can explain an apparent disagreement without anyone being wrong.

The agency would prepare conditional page briefs only after that verification. Where a claim cannot be traced to a current primary source, it stays out of the correction queue rather than being treated as an error. This keeps proposed edits grounded in confirmed facts.

Step 3. Align the external narrative

Questions This Section Answers

  • Which cited third-party pages are relevant to fact review for Illume Fertility?

Cited page selected for review

Citation appearances in all captured answers

Answers mentioning the company

Conflicting claims linked to this page

https://aspirefertility.com/blog/side-effects-of-ivf-stimulation-drugs

3

3

0

https://fertilityindy.com/blog/common-side-effects-of-fertility-medications

3

3

0

https://springfertility.com/theblast/recovery-after-egg-retrieval-what-to-expect-and-how-to-expedite-healing/

6

2

0

https://cnyfertility.com/iui-cost/

3

2

0

https://fertilityiq.com/fertilityiq/iui-or-artificial-insemination/the-cost-of-iui

2

2

0

https://ccrmivf.com/become-a-patient/fertility-financing-options/ivf-cost/

8

1

0

These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.

The cited pages selected for review cluster around treatment side effects, IUI and IVF costs, and recovery guidance. Several were cited in answers that mention Illume Fertility, but a citation does not show that a page shaped the answer, and none carried a linked conflicting claim in this sample.

The agency would review each page's current contents before proposing anything, then approach publishers only with evidence-backed requests. Requests would be framed as clarifications or additions, with no assumption of publisher error or control over the outcome.

Step 4. Optimize priority company pages

Questions This Section Answers

  • Which observed Illume Fertility website pages should receive review briefs?

Company website page

Citation appearances in all captured answers

Benchmark answers citing the page

Recommending answers citing the page

https://illumefertility.com/pricing-and-insurance/iui-costs

6

6

0

https://illumefertility.com/fertility-blog/in-vitro-fertilization-ivf-side-effects-at-each-stage

3

3

0

https://illumefertility.com/fertility-blog/how-to-find-a-pcos-specialist-near-me

2

2

0

https://illumefertility.com/fertility-blog/ivf-dos-and-donts

2

2

0

https://illumefertility.com/fertility-blog/acupuncture-for-ivf

1

1

0

https://illumefertility.com/fertility-blog/are-at-home-sperm-tests-accurate

1

1

0

https://illumefertility.com/fertility-blog/average-cost-of-surrogacy-in-the-united-states

1

1

0

https://illumefertility.com/fertility-blog/does-my-insurance-cover-ivf

1

1

0

The company's website was cited 34 times across 25 distinct page addresses; the table shows 8 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.

The clinic's own pages were cited across a range of cost, side-effect and practical-guidance topics, with the IUI cost page drawing the most appearances. None of those citations came from answers that also recommended the company, which suggests the pages inform answers without yet accompanying endorsement.

The agency would draft page briefs for the listed pages using approved facts and the audience questions observed in the research. Each brief would check existing coverage first, so new work strengthens what is already cited rather than duplicating it.

Step 5. Publish around buyer questions

Questions This Section Answers

  • Which observed buyer questions support content briefs for Illume Fertility?

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

fertility nutritionist

1

1

1

lgbt fertility clinic

1

1

1

lgbtq fertility clinic

1

1

1

Does insurance normally cover IVF?

1

1

0

How accurate is an at-home fertility test?

1

1

0

How can I do IVF if I can't afford it?

1

1

0

How is mini IVF different from regular IVF?

1

1

0

How much do 3 rounds of IUI cost?

1

1

0

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

The recorded questions span insurance coverage, affordability, at-home testing, mini IVF and IUI costs, alongside identity-specific searches for LGBT and LGBTQ fertility clinics and a fertility nutritionist. Illume Fertility was mentioned in answers to each, and the identity-related questions also carried recommendations.

The agency would turn these into buyer-question content briefs, checking existing pages before proposing anything new. The questions are recorded answer observations, not verified search demand, so briefs would be prioritized by fit with the clinic's services rather than by assumed volume.

Our 90-day action plan

Questions This Section Answers

  • How should the agency sequence the proposed Illume Fertility work and judge completion?

Period

Deliverable

Completion criterion

Days 1–30

Baseline scorecard, scoped fact-review register and page/source shortlist

Each record has an owner, evidence requirement and review status

Days 31–60

Approved page briefs and justified publisher requests

Separate confirmed edits, no-change decisions, requests and responses

Days 61–90

Buyer-content briefs and a fresh scorecard

Record work completed separately from measured answer outcomes and comparability limits

The first month establishes the baseline scorecard, a scoped fact-review register and a page and source shortlist, each with an owner and review status. The second month produces approved page briefs and justified publisher requests, with confirmed edits, no-change decisions and responses recorded separately.

The final month delivers buyer-content briefs and a fresh scorecard. Completed work is reported apart from measured answer outcomes, and comparability limits are stated alongside any change, so delivery is never presented as proof of improved visibility.

Methodology

Questions This Section Answers

  • How are Illume Fertility answer metrics and citation populations defined?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 479 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 669 captured answers and 4253 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

Reporting month

Answers included

AI services covered

Services

Nov 2026

479

6

ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity

Earlier editions (July 2026, August 2026, September 2026 and October 2026) used a narrower set of questions. This edition includes all captured answers screened as relevant and establishes a broader baseline. Earlier figures remain in the archive; they are not used to claim a change in performance.

Future editions using the same screening scope can be compared against this baseline.

The benchmark covers answers that met inclusion rules, and a company counts as recommended only when an answer endorses it with positive wording. Top-three and first-place counts sit inside those recommendations rather than adding to them. Answers can name several companies, so company counts do not sum to distinct answers.

Collection dates for the original answers are unverified, and cited pages and disputed claims still need independent checking. Earlier editions used a narrower question set, so this edition is a broader baseline rather than a performance trend.

Our first three priorities

First, confirm the baseline and build the scorecard so reach and endorsement are tracked separately from the outset. Second, verify the cited cost and side-effect pages against current primary sources before any publisher request or page brief is drafted, keeping unconfirmed claims out of the correction queue.

Third, prepare buyer-question briefs around insurance, affordability and identity-specific care, checking existing coverage first. These are proposed work items; none of them guarantees a change in how AI answers describe or recommend the clinic.

This report supports CiteWorks Studio's examination of how AI search is recommending Fertility Clinics. For more detail, you can also read Fertility Clinics: AI Visibility Discovery Index.

/ Learn More

Understanding AI search visibility.

AI search experiences create answers by pulling information from many places online and summarizing it into a single response.

What Is AI Citation Intelligence?
AI citation intelligence is the process of measuring where AI platforms source their information and how frequently a brand is mentioned or referenced in AI-generated responses. Because LLMs synthesize across multiple sources, the sites and brands that appear repeatedly tend to influence how a topic or company is framed. This practice focuses on identifying which sources shape AI outputs and tracking brand visibility across different AI systems.
What Is Citation Architecture?
Citation architecture describes the set of sources that consistently inform how AI systems talk about a brand, product, or topic. LLMs draw from websites, articles, forums, and public discussion, and the sources they rely on most often become the backbone of their answers. Building strong citation architecture means ensuring that accurate, credible, high authority sources are the ones most likely to shape the way AI tools summarize and recommend a brand.
What Is Generative Engine Optimization?
Generative engine optimization (GEO) is the practice of improving the chances that AI systems use and cite your brand or content when generating answers. While traditional SEO is centered on ranking pages in search results, GEO focuses on how LLMs retrieve, interpret, and combine information when responding to a question. The objective is to strengthen the content and sources AI systems rely on, so your brand is treated as a trusted reference in AI responses.
What Is AI Share of Voice?
AI share of voice tracks how often a brand appears in AI-generated answers compared with competitors in the same category. It reflects visibility across AI platforms such as ChatGPT, Gemini, Claude, and Perplexity. Monitoring AI share of voice helps organizations see whether AI systems consistently include and recommend their brand for key queries or whether competitor brands are showing up more often.

About The Author

Mark Huntley

Mark Huntley

Founder and CEO

Mark Huntley, J.D. is founder of CiteWorks Studio, a strategic advisory focused on visibility, authority, and recommendation presence in AI-shaped search environments. His work centers on embedding-level GEO, vector optimization, and cosine gap engineering — helping brands align their digital presence with the retrieval systems that increasingly shape discovery, interpretation, and choice.

VIEW ALL CASE STUDIESREQUEST AN AI VISIBILITY AUDIT